Related Experiment Video

Updated: Dec 5, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.5K

Clinical and Histopathologic Characteristics of the Main Causes of Vascular Occusion - Part II: Coagulation

M J Beato Merino1, A Diago2, A Fernandez-Flores3

  • 1Servicio de Anatomía Patológica, Hospital Universitario La Paz, Madrid, España.

Actas Dermo-Sifiliograficas
|October 19, 2020
PubMed

Insights

This review explores diverse causes of vascular occlusion beyond thrombi, detailing conditions with potentially severe clinical outcomes. Understanding these additional factors is crucial for effective patient management and treatment strategies.

Area of Science:

  • Cardiovascular Medicine
  • Pathology

Background:

  • Vascular occlusion presents with varied clinical manifestations and significant patient consequences.
  • Thrombi, a common cause, were discussed in Part I of this review.
  • This review focuses on non-thrombotic causes of vascular occlusion.

Purpose of the Study:

  • To elucidate additional, non-thrombotic etiologies of vascular occlusion.
  • To provide a comprehensive overview of vascular occlusion causes.
  • To inform clinical practice regarding diverse vascular occlusion mechanisms.

Main Methods:

  • Literature review of non-thrombotic vascular occlusion causes.
  • Synthesis of information on diverse etiologies.
  • Categorization of additional causes of vascular occlusion.

Main Results:

  • Identified and detailed multiple non-thrombotic causes of vascular occlusion.
  • Highlighted the diverse clinical presentations associated with these causes.
  • Emphasized the potential for grave patient outcomes.

Conclusions:

  • Vascular occlusion stems from various causes beyond thrombi.
  • Recognizing these additional causes is vital for accurate diagnosis.
  • Comprehensive understanding improves patient care and prognosis.

Keywords:
Blood coagulation disordersCalcifilaxisCalciphylaxisCoagulación intravascular diseminadaCoagulopatíaDegos diseaseDisseminated intravascular coagulationEnfermedad de DegosLivedoid vasculopathyVasculopatía livedoide

More Related Videos

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.8K
Microvascular Embolism Mouse Model for In Vivo Two-photon Microscopy Using Fluorescent Polystyrene Microspheres08:44

Microvascular Embolism Mouse Model for In Vivo Two-photon Microscopy Using Fluorescent Polystyrene Microspheres

Published on: November 21, 2025

59

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.7K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
151
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.3K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
167
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
167
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.1K